Insider filing · BCAX
Ryan Cohlhepp
President, COO & Interim CEO
profile →
Bicara Therapeutics Inc.
BCAX · Healthcare · 40 filings in 24 months
ticker →
Ryan Cohlhepp sold $320K of Bicara Therapeutics (BCAX)
Executed Sep 8, disclosed Sep 10, 2 days later.
Value, as filed
$320K
14,058 sh × $22.77
Executed
Sep 8
the trade date, as filed
Disclosed
Sep 10
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RCRyan Cohlhepp (President, COO & Interim CEO) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $860K of BCAX (47,600 sh across 3 lots, as filed), executed Oct 6 2025.
The name
BCAXHealthcare · Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Ryan Cohlhepp in BCAX
BCAXSALE
Bicara Therapeutics Inc.
$525K18,750 sh × $27.98
Exec Aug 10
Filed Aug 12 · 4:19 PM ET BCAXSALE Bicara Therapeutics Inc. $785K
27,139 sh across 2 lots
Exec Jul 8
Filed Jul 10 · 4:10 PM ET BCAXSALE Bicara Therapeutics Inc. $162K
8,000 sh × $20.29
Exec May 15
Filed May 18 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $288K
12,500 sh across 2 lots
Exec Apr 15
Filed Apr 17 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $157K
8,000 sh × $19.66
Exec Mar 16
Filed Mar 17 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $234K
12,892 sh × $18.16
Exec Mar 3
Filed Mar 5 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $149K
8,000 sh × $18.68
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $144K
8,000 sh × $18.05
Exec Nov 21 2025
Filed Nov 25 2025 · 5:30 PM ET